Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Name: Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
Published: 2009
License: Public Domain

Eli Lilly and Company · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

angiogenesis gastric-cancer

gastric cancer, adenocarcinoma, imc-1121b, monoclonal antibody (mab), vascular endothelial growth factor (vegf), human vascular endothelial growth factor receptor-2 (vegfr-2), platinum resistant, platinum refractory, gastric, gastroesophageal junction adenocarcinoma, metastatic, angiogenesis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 828932
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.